Position in ARDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,073,830
-$102,108 QoQ
Shares Held
210,555
+7.3% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 250 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $496,588,000 across 51 Biotechnology names. ARDX ranks #33 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TWST |
Twist Bioscience Corp
|
1,433,503 | $147,478,787 | |
| 2 | EXEL |
Exelixis, Inc.
|
1,620,743 | $88,184,625 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
131,457 | $81,968,697 | |
| 4 | RPRX |
Royalty Pharma plc
|
740,772 | $41,535,085 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
80,500 | $19,398,084 | |
| 6 | ARGX |
Argenx SE
|
12,688 | $11,771,545 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,169 | $10,018,546 | |
| 8 | VCEL |
Vericel Corp
|
170,272 | $7,575,400 |
All Filings in ARDX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,073,830 | 210,555 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,175,938 | 196,317 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $949,042 | 162,786 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $861,918 | 156,428 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $805,340 | 205,444 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $2,124,090 | 432,605 | Shares | Defined | 2025-08-26 | |
| 2021-06-30 | $14,522,839 | 1,915,942 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $16,119,229 | 2,434,929 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,421,464 | 2,074,415 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||